Clinical Trial Update: A Study to Examine Past Estimated Glomerular Filtration Rate (eGFR) Slope as a Risk Marker for Rapid Kidney Function Decline in People With Chronic Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 trial investigating eGFR slope as a risk marker for rapid kidney function decline in chronic kidney disease; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Chronic Kidney Disease | Phase 2 | Status: TERMINATED | Results posted: 2023-08-04